Michael Dickinson, MBBS, DMedSc, on ASH Glofitamab Updates

By Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA - Last Updated: January 13, 2023

Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA, of the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, discusses updates on glofitamab, a bispecific antibody for the treatment of relapsed or refractory diffuse large B-cell lymphoma, that were presented during the 2022 American Society Hematology Annual Meeting.

Advertisement
Editorial Board

Advertisement